Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
NCT00258128Phase 2Completed
- Sponsor
- Joslin Diabetes Center
- Start
- Jan 2000
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Amigesic in insulin resistance (IR), sponsored by Joslin Diabetes Center. Started Jan 2000; status: completed.
02
Drugs
Amigesic
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT00258128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258128.